Sensitivity and Specificity of the Clinical Classifications Generated by the Cureety Digital Telemonitoring Tool
NCT ID: NCT05653609
Last Updated: 2023-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2022-11-15
2022-12-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The patients are asked to respond to an electronic patient-reported outcome (ePRO) questionnaire. The digital tool is configured for each patient that generates specific questions that allow grading of adverse events relevant to their specific treatment and disease profile.
At the core of the platform is the medical device "Cureety TechCare", an algorithm that outputs a "clinical classification" based on the adverse events reported by the patients. There are four levels that correspond to the patients' health states, either "critical" ("red"), "to be monitored" ("orange"), "compromised" ("yellow"), or "correct" ("green"). In the case of a red or orange classification, the patients are asked to contact their medical team. In addition, the medical team can monitor the patient classifications from a distance including receiving notifications when patients are classified red and orange.
The present study was designed to retrospectively evaluate the performance of the "Cureety TechCare" medical device in real-life using data collected in the Cureety database.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telematics Device for Daily Monitoring of Vital Signs in Cancer
NCT05650814
Home Monitoring During Chemoradiation
NCT06597240
Elderly Chronic Diseases Online Biometric Analysis Home Living Technology
NCT02155686
Seniors Guardian: A Monitoring Platform for the Elderly
NCT03891771
Continous Monitoring of Vital Signs on Hospitalized Cancer Patients.
NCT04299230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemonitoring
Patients monitored by the Cureety digital platform
Cureety TechCare
Weekly adverse event questionnaires completed by the patients using a digital tool called Cureety
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cureety TechCare
Weekly adverse event questionnaires completed by the patients using a digital tool called Cureety
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients that have completed at least one questionnaire in Cureety
* Patients that have not exercised their right to oppose to the use of their data for clinical research.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cureety
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cureety
Dinan, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTC-2022-11-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.